Psychiatry and Neurology, Neurology · Golden Valley, MN
NPI
1225271646
Since 2009
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
4225 Golden Valley Rd
Golden Valley, MN, 55422
Phone (763) 588-0661
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.6M
62,742 services
Medicare patients, 2024
229
Average age 64
Drug cost, 2024
$3.3M
3,612 prescriptions
Company payments, 2025
$31K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica L Stulc was code J2350 (injection, ocrelizumab, 1 mg), 39,600 times for 39 patients. In total Jessica L Stulc billed 62,742 services in 41 codes, and Medicare paid $2.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2350 Injection, ocrelizumab, 1 mg | Office | 39,600 | 39 | $43.51 | $1.7M |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,775 | 40 | $0.22 | $623 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 195 | 147 | $12.94 | $2,523 |
| 99215 Office E&M - Established | Office | 136 | 99 | $135.47 | $18K |
| 96415 Chemotherapy Administration | Office | 121 | 43 | $22.66 | $2,742 |
| 99214 Office E&M - Established | Office | 111 | 92 | $93.48 | $10K |
| 96413 Chemotherapy Administration | Office | 80 | 43 | $105.42 | $8,433 |
| 96375 Injection Administration | Office | 76 | 42 | $12.04 | $915 |
| 70553 MRI/MRA - Head and Neck | Office | 54 | 49 | $175.01 | $9,451 |
| 72156 MRI/MRA - Spine | Office | 52 | 48 | $175.26 | $9,113 |
| 72157 MRI/MRA - Spine | Office | 51 | 47 | $266.88 | $14K |
| J2930 Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 47 | 23 | $4.32 | $203 |
| 99213 Office E&M - Established | Office | 45 | 42 | $53.95 | $2,428 |
| 70551 MRI/MRA - Head and Neck | Office | 39 | 39 | $166.25 | $6,484 |
| 72141 MRI/MRA - Spine | Office | 32 | 32 | $107.28 | $3,433 |
By year: 2022 $2.3M for 58,128 services; 2023 $2.7M for 61,337 services; 2024 $2.6M for 62,742 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jessica L Stulc prescribed most often to Medicare patients was Gabapentin, with 448 prescriptions and refills. In total Jessica L Stulc wrote 3,612 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 448 | 972 | 110 | $15K |
| Baclofen Generic | 410 | 981 | 116 | $15K |
| Clonazepam Generic | 176 | 253 | 33 | $1,555 |
| Dalfampridine Er Dalfampridine | 130 | 234 | 27 | $49K |
| Pregabalin Generic | 124 | 234 | 31 | $3,840 |
| Duloxetine Hcl Generic | 115 | 300 | 24 | $3,369 |
| Kesimpta Pen Ofatumumab | 112 | 112 | 13 | $1.0M |
| Tizanidine Hcl Generic | 112 | 239 | 27 | $4,674 |
| Diazepam Generic | 107 | 123 | 42 | $414 |
| Modafinil Generic | 103 | 201 | 25 | $7,386 |
| Teriflunomide Generic | 95 | 129 | 17 | $103K |
| Levetiracetam Generic | 66 | 171 | 18 | $2,243 |
| Copaxone Glatiramer Acetate | 64 | 71 | Under 11 | $439K |
| Glatiramer Acetate Generic | 61 | 67 | Under 11 | $130K |
| Emgality Pen Galcanezumab-Gnlm | 52 | 52 | Under 11 | $37K |
Brand drugs: - claims; generic drugs: 3,172 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica L Stulc $31K ($31K in general payments such as food, travel and fees) from 13 companies. The largest payer was EMD Serono, Inc. with $28K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.